Results 121 to 130 of about 46,899 (191)

Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy. [PDF]

Br J Cancer
Matsubara Y, Bando H, Nakamura Y, Misumi T, Ng D, Tajima E, Pittell H, Ohtsu A, Yoshino T.   +8 more
europepmc   +1 more source

Dose-Dependent Inhibition of Protein Glycosylation Reveals Crosstalk between Glycosylation and Phosphorylation in EGF Signaling Pathways. [PDF]

Anal Chem
Liu H, Lin DC, Hu Y, Sun Z, Huang Y, Xu Y, Zhang H.   +6 more
europepmc   +1 more source

Amphiregulin and Epiregulin Confer Radioresistance in Esophageal Squamous Cell Carcinoma Through Oxidative Phosphorylation. [PDF]

Adv Sci (Weinh)
Lin Z, Yao M, Xu X, Zhang D, Xu L, Rong L, Wang X, Duan Y, Chen C, Gu J, Zhang Y, Liu Q, Ye Q, Cui G, Hao Y, Ma X.   +15 more
europepmc   +1 more source

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes. [PDF]

FEBS J
Vaparanta K, Song Z, Farahani I, Jokilammi A, Merilahti J, Örling J, Virtanen N, Haapaniemi P, Sahlgren C, Elenius K, Paatero I.   +10 more
europepmc   +1 more source

ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report. [PDF]

AME Case Rep
Gao HF, Lin YY, Lv XZ, Li H, Xu FP, Wang K.   +5 more
europepmc   +1 more source

Increased activation of ErbB and NF-κB signalling pathways in Darier disease affected skin. [PDF]

J Eur Acad Dermatol Venereol
Ernst N, Ludwig RJ, Vorobyev A.
europepmc   +1 more source

Construction of TF-lncRNA-miRNA-mRNA Regulatory Network Affecting Sow Reproduction Based on QTLs for Corpus Luteum Number. [PDF]

Animals (Basel)
Wang M, Lu M, Gao Y, Wang C, Xu T, Yang C, Liu Y.   +6 more
europepmc   +1 more source

Human Mesenchymal Stromal Cells Derived from Different Tissues Show Similar Profiles of c-ErbB Receptor Family Expression at the mRNA and Protein Levels. [PDF]

Int J Mol Sci
Kosheverova V, Kharchenko M, Kamentseva R, Kotov M, Schwarz A, Kuneev I, Kotova A, Enukashvily N, Kornilova E.   +8 more
europepmc   +1 more source

The future of urothelial carcinoma: a 2024-2025 update of early-phase trials of novel therapeutic agents. [PDF]

Curr Opin Urol
Lee YHA, Wong CM, Liu AQ, Teoh JY.
europepmc   +1 more source